EMJ GOLD: Pharma news, views and analysis

The GOLD Podcast is back and better than ever! Tune into the first episode of Season 2 to hear the news you might have missed, exclusive extracts from GOLD's catalyst interview with Judy Stewart, Senior Vice President and Head of US Vaccines, GSK, as well as a fascinating conversation with Independent Pharma Broker and blockchain enthusiast, Vincent Steine. Click here to subscribe to the weekly newsletter for more insights from GOLD. https://www.emg-gold.com/subscribe If you are interested in learning more about the topic areas discussed in this episode, check out the following content: GSK warns against routine vaccine complacency https://www.emg-gold.com/post/gsk-warns-against-routine-vaccine-complacency Avalere Study – 'How COVID-19 Has Impacted US Adolescent and Adult Vaccine Utilization': https://avalere.com/insights/how-covid-19-has-impacted-us-adolescent-and-adult-vaccine-utilization Hear more from Judy Stewart: "We've lost the focus that we had on routine vaccination of preventable diseases" https://www.emg-gold.com/post/we-ve-lost-the-focus-that-we-had-on-routine-vaccination-of-preventable-diseases

We're back! The next season of the GOLD Podcast launches on 15th February with a brand new format, more high profile guests and fresh industry insights – subscribe now to be the first to join hosts Marc and Helena and hear new episodes.

For the season finale of the GOLD Podcast, we look back at our 'GOLD Medal Moments' from the past 12 months, revisiting interviews with some of our top guests. Marc and Helena pick out the most important and challenging topics from 2021, including combatting misinformation, the evolving role of medical affairs, improving access to medicine and producing results in times of crisis.

In this episode, we talk to Margo Warren, Head of Policy at the Access to Medicine Foundation, who offers her thoughts on the ever-present need for global access to medicine. Margo discusses her path into the fight for health equality, the importance of global vaccine distribution, the changing philosophies behind bringing a product to market, and the move from reactive to pre-emptive research and development.

Join us in kicking off the new year with a special episode of the GOLD podcast, welcoming back six of our previous guests to share their predictions for what 2022 could bring for the pharmaceutical industry. They discuss a broad spectrum of topics ranging from new tech trends and clinical trial developments, to improvements in diversity and inclusion and patient centricity.

In this special end-of-year round up episode, three of this year's GOLD Podcast guests return to review 2021 in the pharmaceutical industry. They discuss topics ranging from industry reputation to vaccine access, and celebrate and critique the year just past, while also looking ahead to 2022.

In this episode, we talk to Catherine Owen, Head of Major Markets at Bristol Myers Squibb, who discusses her path into the pharmaceutical industry and the upcoming changes to its data policies. Catherine explores the collection and storage of data, how we can ensure data systems are in place for the next pandemic, methods to build a new data culture and her key takeaways from the past year in pharma.

This week, we reflect on the highlights from the pharmaceutical industry that took place in November, covering the latest in COVID-19 developments, the most notable mergers and acquisitions, the standout awareness campaigns, and the latest in research and development news.

We talk to Tamika Jean-Baptiste, Vice President and Chief Diversity Officer, Amgen, who discusses her lifelong passion for diversity both in the workplace and in life. Tamika explores the importance of aligning your purpose and your passion, how best to draw young people into pharma, leveraging employee resource groups, and the significance of filling your own cup before reaching for others.

We speak to Chumi Khurana, Global Head, Prostate Cancer Disease Area Stronghold, Janssen Oncology about her pathway into men's health, the challenges and potential solutions in the realm of prostate disease, and her advice for family and caregivers on how best to support a loved one who is dealing with a prostate cancer diagnosis.